World Equity Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,155
| Closed | -$767K | – | 261 |
|
|
2024
Q2 | $767K | Hold |
3,155
| – | – | 0.23% | 113 |
|
|
2024
Q1 | $472K | Buy |
3,155
+142
| +5% | +$21.2K | 0.1% | 194 |
|
|
2023
Q4 | $577K | Sell |
3,013
-380
| -11% | -$72.7K | 0.12% | 176 |
|
|
2023
Q3 | $601K | Buy |
3,393
+333
| +11% | +$59K | 0.12% | 179 |
|
|
2023
Q2 | $581K | Sell |
3,060
-30,380
| -91% | -$5.77M | 0.17% | 154 |
|
|
2023
Q1 | $863K | Buy |
33,440
+30,466
| +1,024% | +$786K | 0.13% | 183 |
|
|
2022
Q4 | $707K | Sell |
2,974
-31
| -1% | -$7.37K | 0.17% | 140 |
|
|
2022
Q3 | $601K | Sell |
3,005
-44
| -1% | -$8.81K | 0.15% | 142 |
|
|
2022
Q2 | $445K | Sell |
3,049
-47
| -2% | -$6.86K | 0.11% | 200 |
|
|
2022
Q1 | $506K | Buy |
+3,096
| New | +$506K | 0.11% | 210 |
|